Clinical Trial Update: Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis [Phase 2]

View source ↗

Summary

A Phase 2 exploratory trial update evaluating the radiotracer [68Ga]Ga-FAPI-46 for staging and identifying progressing patients with transthyretin amyloid cardi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Drugs mentioned

• [68Ga]Ga-FAPI-46

Snippet

Sponsor: Nantes University Hospital | Conditions: Transthyretin Cardiac Amyloidosis | Phase 2 | Status: NOT_YET_RECRUITING